Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Immunotherapy for non-Hodgkin lymphoma. U.S. Food & Drug Administration. Highlights Of prescribing information: Arzerra. Levit L, Balogh E, Nass S, et al. Patient-Centered Communication and Shared ...

How Does Polycythemia Vera Advance? Polycythemia vera affects your bone marrow, the spongy tissue in the center of your bones that makes blood cells. The disease causes your bone marrow to make ...

There are two types of lymphoma: Hodgkin's lymphoma and non-Hodgkin's lymphoma. Most B-cell lymphomas are non-Hodgkin's lymphoma. B-cell lymphomas come in many types. Some grow quickly and others ...

FAYETTE - Doris Irene (Hodgkins) Morris, 85, of Fayette, passed away peacefully on Feb. 16, 2025, at the Augusta Center for ... FAYETTE – Doris Irene (Hodgkins) Morris, 85, of Fayette ...

CHOP Expert Commentary, August 30, 2017 ALK-positive Anaplastic LCL in a Patient With TB This case highlights the clinical and pathological features that tuberculosis and lymphoma can share ...

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is this week’s cancer news.

According to a 2018 review, autologous transplants are the standard treatment for young, otherwise healthy people with Hodgkin’s lymphoma if initial treatments have been ineffective. The ...